the Web site devoted to the study of the glucagon-like peptides

This Web site is maintained by Dr. Daniel J. Drucker, Mount Sinai Hospital Lunenfeld-Tanenbaum Research Institute University of Toronto

Lixisenatide ELIXA study reports top line safety data for MACE outcomes-full presentation June 8 in Boston at ADA

Save the dates-Lunenfeld Tanenbaum Symposium Molecular concepts and translational innovation in metabolism May 26 2015

Incretin 2015-The 45th Anniversary of GIP and more: Vancouver July 29-August 1 2015


For updates to, Follow us on Twitter DanielJDrucker